Login to Your Account

FDA's cancer moonshot aims at toppling drug and device silos

By Mari Serebrov
Regulatory Editor

Thursday, February 25, 2016

In shooting for the moon with cancer research, the FDA must pull down the silos between researchers and breach the internal barriers separating its own oncology experts on drugs, diagnostics and devices, acting FDA Commissioner Stephen Ostroff told a House Appropriations subcommittee Thursday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription